Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ayer, D. E., Kretzner, L. & Eisenman, R. N. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 72, 211–222 (1993).
Hurlin, P. J. et al. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation. EMBO J. 14, 5646–5659 (1995).
Zervos, A. S., Gyuris, J. & Brent, R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell 72, 223–232 (1993).
Schreiber-Agus, N. et al. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80, 777–786 (1995).
Ayer, D. E., Lawrence, Q. A. & Eisenman, R. N. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 80, 767–776 (1995).
Schreiber-Agus, N. & DePinho, R. A. Repression by the Mad(Mxi1)-Sin3 complex. Bioessays(in the press).
Henriksson, M. & Luscher, B. Proteins of the Myc network: essential regulators of cell growth and differentiation. Adv. Cancer Res. 68, 109–182 (1996).
Edelhoff, S. et al. Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. Oncogene 9, 665–668 (1994).
Shapiro, D. N. et al. Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. Genomics 23, 282–285 (1994).
Wechsler, D. S. et al. Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q25. Genomics 21, 669–672 (1994).
Adams, J. M. et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318, 533–538 (1985).
Harris, A. W. et al. Transgenic mouse models for hematopoietic tumorigenesis. Curr. Top. Microbiol. Immunol. 141, 82–93 (1988).
Yukawa, K. et al. Strain dependency of B and T lymphoma development in immunoglobulin heavy chain enhancer (E mu)-myc transgenic mice. J. Exp. Med. 170, 711–726 (1989).
Cowley, B. D. J, Chadwick, L. J., Grantham, J. J. & Calvet, J. P. Elevated proto-oncogene expression in polycystic kidneys of the C57BL/6J (cpk) mouse. J. Am. Soc. Nephrol. 1, 1048–1053 (1991).
Trudel, M., D'Agati, V. & Constantini, F. C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int. 39, 665–671 (1991).
Dedeoglu, I. O. et al. Spectrum of glomerulocystic kidneys: a case report and review of the literature. Ped. Path. Lab. Med. 16, 941–949 (1996).
Foley, K. P. et al. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation. EMBO J. 17, 774–785 (1998).
Gerlach, C. et al. Ki-67 immunoexpression is a robust marker of proliferative cels in the rat. Lab. Invest. 77, 697–698 (1997).
Hecker, E. et al. International symposium: skin carcinogenesis in man and in experimental models. J. Cancer Res. Clin. Oncol. 118, 321–328 (1992).
Serrano, M. et al. Role of the INK4a locus in tumor suppression and cell mortality. Cell 85, 27–37 (1996).
Serrano, M. et al. Inhibition of ras-induced proliferation and cellular transformation by p16INK4. Science 267, 249–252 (1995).
Pomerantz, J. et al. The INK4a tumor suppressor gene product, p19ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 92, 713–723 (1998).
Li, J. et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 275, 1943–1947 (1997).
Kawamata, N. et al. Point mutations of the Mxi1 gene are rare in prostate cancers. Prostate 29, 191–193 (1996).
Gray, I. C. et al. Loss of the chromosomal region 10q23-25 in prostate cancer. Cancer Res. 55, 4800–4803 (1995).
Prochownik, E. V. et al. Commonly occurring loss and mutation of the MXI1 gene in prostate cancer. Genes Chromosom. Cancer(in the press).
Jenkins, R. B., Qian, J., Lieber, M. M. & Bostwick, D. G. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization. Cancer Res. 57, 524–531 (1997).